Cromoglicate in Psoriasis

NCT01722812 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Cromoglicate
DRUG: Placebo

Sponsor

LEO Pharma